Project Description

Cellular Preservation Technologies (CPT)
How Extending The Shelf Life Of Platelets Can Save Thousands Of Lives Per Year

Date & Time:

October 26, 4:00 PM ET / 1:00 PM PT
Webinar: Details provided upon RSVP approval

About the Event:

Platelets are crucial in treating a number of diseases, yet every year 10% of our supply of life-saving platelets are wasted due to their extremely short shelf life. This costs millions of dollars and endangers thousands of lives.

Cellular Preservation Technologies (CPT) has developed a patented medical device that increases the shelf life of platelets to 14 days working with the Vitalant, American Red Cross, Mayo Clinic, and others.

Hear why this is such a critical issue from Larry Dumont, M.B.A., Ph.D., Director & Senior investigator at the Vitalant Research Institute. Vitalant is the nation’s largest independent, nonprofit blood services provider.

Please join our webinar to hear Cellular Preservation Technology CEO, John Librie and Dr. Dumont discuss how extending the shelf life of platelets can save thousands of lives, millions of dollars, and become standard equipment at every blood center and medical lab in the country.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.